A 31-year-old man felt sudden chest pain while at work. His colleagues on noticing his discomfort rushed him to the hospital. He was diagnosed with Myocardial Infarction and underwent Coronary Artery Bypass Graft (CABG). He and his family members were suggested to undergo Coronary Artery Disease -Polygenic Risk Score (CAD-PRS) Test to determine their genetic risk for Coronary Artery Disease (CAD).
Strong paternal history of heart disease was observed. Two uncles, father and grandfather underwent CABG at a young age. He first opted for the CAD-PRS Test. His family members were also tested for the same, especially his younger siblings
Coronary Artery Disease -Polygenic Risk Score Testing for the proband and his immediate family was done at MedGenome
The 31 year old man, father and brother were found to have a population high polygenic risk, the mother has a moderate risk and sister has an average risk.

| Sample | Age | Gender | CAD PRS | Odds Ration | Risk |
| Proband | 31 | Male | 1.028 | 2.53 | High |
| Father | 56 | Male | 0.79 | 1.67 | High |
| Mother | 53 | Female | -0.01 | <1 | Moderate |
| Brother | 25 | Male | 1.77 | 2.42 | High |
| Sister | 26 | Female | -0.345 | <1 | Average |
The Coronary Artery Disease - Polygenic Risk Score (CAD-PRS) for the man who underwent CABG was found to be 1.028. This score has been profiled as a high risk as observed in MedGenome's study cohort of South Asian ancestry. On testing his younger siblings and mother to determine the risk for coronary artery disease we have found that the brother has a high risk and mother has a moderate risk. The results of the CAD PRS test have alerted the younger brother and the mother to their risk of developing CAD thus helping them be more vigilant and conscious of their diet and lifestyle.
| Test code | Test Name | Sample | TAT |
| MGM1473 | Polygenic Risk Score for Coronary Artery Disease | 3 ml blood in EDTA tubes | 10 working days |
MedGenome offers highly accurate genetic testing services, including Non-Invasive Prenatal Testing (NIPT), Genetic Carrier Screening, Preimplantation Genetic Screening and Diagnosis (PGS/PGD), as well as Product of Conception (POC) testing. In addition, MedGenome provides on-demand genetic counselling both before and after testing for all patients.
Preimplantation Genetic Screening
Day 5 (few cells) embryon biopsy or Day3 (single cell)
Informed Consent Form & Test Requisition Form
7 working days


At MedGenome, scientific experts drive the development of innovative omics solutions that enable early detection of complex diseases. With advanced global-quality next-generation sequencing and proprietary analysis pipelines, the team consistently delivers tests and services that are transforming the way diseases are diagnosed and treated.
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100 Toll free number: 1800 296 9696
*Explore our range of CAP-accredited tests- Click to know more